OIKE NAOKI

オオイケナオキ | OIKE NAOKI

Affiliation and department：
Job title： Assistant professor
Research theme for competitive and other funds (1)：

2022 - 2024 Development of novel NK cell therapy for soft tissue sarcoma

Papers (18)：

Osamu Ansai, Ryota Hayashi, Anna Nakamura, Jin Sasaki, Akito Hasegawa, Tokiko Deguchi, Akihiko Yuki, Naoki Oike, Takashi Ariizumi, Masahiro Abe, et al. Deep dermatophytosis caused by Trichophyton rubrum in an elderly patient with CARD9 deficiency: A case report and literature review. The Journal of dermatology. 2024. 51. 2. 294-300
Yudai Murayama, Yasushi Kasahara, Nobuhiro Kubo, Chansu Shin, Masaru Imamura, Naoki Oike, Takashi Ariizumi, Akihiko Saitoh, Minori Baba, Tomohiro Miyazaki, et al. NKp44-based chimeric antigen receptor effectively redirects primary T cells against synovial sarcoma. Translational oncology. 2022. 25. 101521-101521
Takashi Ariizumi, Hiroyuki Kawashima, Tetsuro Yamagishi, Naoki Oike, Yudai Murayama, Hajime Umezu, Naoto Endo, Akira Ogose. Diagnostic accuracy of fine needle aspiration cytology and core needle biopsy in bone and soft tissue tumor: A comparative study of the image-guided and blindly performed procedure. Annals of diagnostic pathology. 2022. 59. 151936-151936
Naoki Oike, Hiroyuki Kawashima, Akira Ogose, Hiroshi Hatano, Takashi Ariizumi, Tetsuro Yamagishi, Yudai Murayama, Hajime Umezu, Chihaya Imai, Masanori Hayashi, et al. Human leukocyte antigen I is significantly downregulated in patients with myxoid liposarcomas. Cancer immunology, immunotherapy : CII. 2021. 70. 12. 3489-3499
Yudai Murayama, Hiroyuki Kawashima, Nobuhiro Kubo, Chansu Shin, Yasushi Kasahara, Masaru Imamura, Naoki Oike, Takashi Ariizumi, Akihiko Saitoh, Keichiro Mihara, et al. Effectiveness of 4-1BB-costimulated HER2-targeted chimeric antigen receptor T cell therapy for synovial sarcoma. Translational oncology. 2021. 14. 12. 101227-101227

ｍore...

MISC (34)：

富山泰行, 目良恒, 目良恒, 大池直樹, 野中秀紀, 上野惟, 大橋瑠子, 土屋淳紀, 谷藤理, 望月友晴, et al. Localization of human Adipose tissue-derived mesenchymal stem cells injected intra-articularly for rat cartilage defect repair. 日本軟骨代謝学会プログラム・抄録集. 2020. 33rd. 8. S1822-S1822
川島寛之, 有泉高志, 山岸哲郎, 大池直樹, 遠藤直人, 生越章, 畠野宏史, 佐々木太郎. 軟部肉腫患者に対する新規抗がん剤治療による予後の変化. 日本整形外科学会雑誌. 2019. 93. 6. S1396-S1396
有泉高志, 川島寛之, 山岸哲郎, 大池直樹, 遠藤直人, 生越章. 骨・軟部腫瘍に対する穿刺吸引細胞診ならびに針生検の正確性の検討. 日本整形外科学会雑誌. 2019. 93. 6. S1492-S1492
山岸哲郎, 川島寛之, 生越章, 有泉高志, 大池直樹, 佐々木太郎, 畠野宏史, 遠藤直人. 骨・軟部腫瘍の針生検検体による遺伝子診断の有用性. 日本整形外科学会雑誌. 2019. 93. 6. S1492-S1492
大河原舜太, 川島寛之, 生越章, 堀田哲夫, 有泉高志, 山岸哲郎, 大池直樹, 遠藤直人. 骨軟部肉腫におけるPD-L1の発現. 東北整形災害外科学会雑誌. 2019. 62. 1. 142-143

ｍore...

Professional career (1)：

PH.D (Niigata University)

Awards (2)：

2022/06 - Yujin young Investigator Award
2019/12 - University of Colorado University of Colorado Postdoctoral Association Travelling Award High-throughput drug screening combined with a druggable target CRISPR drop-out screen identifies therapeutic vulnerabilities of BCOR-CCNB3 fusion positive sarcomas

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page